Protection of 6-OHDA neurotoxicity by PGF through FP-ERK-Nrf2 signaling in SH-SY5Y cells

Toxicology. 2021 Feb 28:450:152686. doi: 10.1016/j.tox.2021.152686. Epub 2021 Jan 21.

Abstract

6-Hydroxydopamine (6-OHDA) is a neurotoxin that destroy dopaminergic neurons and widely used to establish animal models of Parkinson's disease. Prostaglandins (PGs) are involved in various cellular processes, including the damage and repair of neuronal cells. However, the function of PGF in neuronal cells remains unclear. In this study, we investigated the effects of PGF against 6-OHDA-mediated toxicity in human neuroblastoma SH-SY5Y cells and elucidated its underlying molecular mechanism. When the cells were treated with 6-OHDA (50 μM) for 6 h, the expression levels of PGF synthetic enzymes; cyclooxygenase-2 and aldo-keto reductase 1C3 as PGF synthase were enhanced in an incubation-time-dependent manner. In addition, the production of PGF was increased in 6-OHDA-treated cells. Fluprostenol, a PGF receptor (FP) agonist (500 nM), suppressed 6-OHDA-induced cell death by decreasing the production of reactive oxygen species (ROS) and increasing the expression of the anti-oxidant genes. These fluprostenol-mediated effects were inhibited by co-treatment with AL8810, an FP receptor antagonist (1 μM) or transfection with FP siRNA (20 nM). Moreover, 6-OHDA-induced phosphorylation of extracellular signal-regulated kinase (ERK), a member of the mitogen-activated protein kinase family, was inhibited by co-incubation with AL8810. Furthermore, fluprostenol itself enhanced ERK phosphorylation and further elevated the 6-OHDA-induced phosphorylation of ERK. In addition, 6-OHDA induced nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2), activating anti-oxidant gene expression, was repressed by co-culturing with AL8810. These results indicate that PGF suppressed 6-OHDA-induced neuronal cell death by enhancing anti-oxidant gene expression via the FP receptor-ERK-Nrf2 signaling. Thus, FP receptor is a potential target for inhibition of ROS-mediated neuronal cell death.

Keywords: 6−OHDA; Cell death; ERK; FP; Nrf2; PGF(2α); SH-SY5Y cells.

MeSH terms

  • Adrenergic Agents / toxicity
  • Cell Line, Tumor
  • Dinoprost / agonists
  • Dinoprost / biosynthesis*
  • Dose-Response Relationship, Drug
  • Humans
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • NF-E2-Related Factor 2 / metabolism*
  • Neuroprotection / drug effects
  • Neuroprotection / physiology*
  • Oxidopamine / toxicity*
  • Prostaglandins F, Synthetic / pharmacology
  • Receptors, Prostaglandin / metabolism*

Substances

  • Adrenergic Agents
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Prostaglandins F, Synthetic
  • Receptors, Prostaglandin
  • prostaglandin F2alpha receptor
  • fluprostenol
  • Oxidopamine
  • Dinoprost